TRPV4 is a human protein-coding gene that provides instructions for making transient receptor potential cation channel subfamily V member 4. The protein forms a calcium-permeable ion channel found in many tissues.
TRPV4 is part of the transient receptor potential channel family. It helps cells respond to physical and chemical signals such as osmotic change, mechanical stress, heat and inflammatory signalling.
Gene and Protein
The TRPV4 gene is located on chromosome 12 at 12q24.11. Its protein product is a non-selective cation channel, which means it can allow positively charged ions, including calcium and sodium, to move across a cell membrane.
The channel has the general structure seen in many TRP channels, with several membrane-spanning regions and intracellular regulatory areas. These regions help the channel respond to stimuli and interact with other cell proteins.
TRPV4 has been described under several older names, including OTRPC4 and VRL2. Modern clinical and genetics sources usually use TRPV4.
Biological Role
TRPV4 is widely expressed. It has been studied in cartilage, bone, nerves, blood vessels, airway tissue, kidney, bladder, skin and other tissues.
The channel is involved in several processes:
- sensing changes in osmotic pressure
- calcium signalling inside cells
- responses to mechanical stretch or shear stress
- cartilage and bone development
- aspects of pain and inflammatory signalling
- regulation of epithelial and vascular function
The importance of TRPV4 comes from its broad tissue expression. A change in channel activity can therefore have different effects depending on which cells are affected.
TRPV4-Related Disorders
Pathogenic variants in TRPV4 are associated with a spectrum of autosomal dominant disorders. GeneReviews groups these mainly into neuromuscular disorders and skeletal dysplasias, although overlap can occur.
Neuromuscular conditions linked to TRPV4 include:
- Charcot-Marie-Tooth disease type 2C
- scapuloperoneal spinal muscular atrophy
- congenital distal spinal muscular atrophy
Skeletal conditions linked to TRPV4 include:
- metatropic dysplasia
- spondylometaphyseal dysplasia, Kozlowski type
- autosomal dominant brachyolmia
- other skeletal dysplasia phenotypes within the TRPV4 spectrum
The severity varies widely. Some people have relatively mild symptoms and a normal lifespan, while severe skeletal dysplasia can cause major disability and shortened survival.
Mechanism
Many disease-causing TRPV4 variants alter channel activity. In skeletal dysplasias, overactive calcium entry in cartilage-forming cells is thought to disturb normal cartilage and bone development.
In neuromuscular disease, the same gene is involved but the main clinical effects are seen in motor nerves and muscles. This difference is one reason TRPV4-related disease is treated as a spectrum rather than a single uniform condition.
Diagnosis
TRPV4-related disorders are diagnosed by combining clinical findings, family history, imaging, neurological examination and genetic testing. The exact pathway depends on whether the person presents with skeletal, nerve or muscle features.
Genetic testing can identify a pathogenic TRPV4 variant, but results need clinical interpretation. Not every variant found in a gene is automatically disease-causing.
Research
Research into TRPV4 focuses on how the channel is gated, how specific variants change calcium signalling, and whether channel-modifying medicines could be useful in selected conditions.
TRPV4 is also studied outside rare genetic disease because ion-channel activity is relevant to pain, lung disease, vascular function and tissue injury.
See Also
References
Discussion log
Use comments for sourcing notes, corrections, and disputed details.
No comments yet.